About: Spark Therapeutics

Property	Value
dbo:abstract	Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche. (en)
dbo:assets	8.14E8
dbo:equity	4.96E8
dbo:foundedBy	dbr:Katherine_A._High
dbo:foundingYear	2013-01-01 (xsd:gYear)
dbo:industry	dbr:Biotechnology
dbo:location	dbr:Pennsylvania dbr:Philadelphia
dbo:netIncome	7.8E7
dbo:numberOfEmployees	368 (xsd:nonNegativeInteger)
dbo:parentCompany	dbr:Hoffmann-La_Roche
dbo:revenue	6.4E7
dbo:thumbnail	wiki-commons:Special:FilePath/Spark_Therapeutics_Label.png?width=300
dbo:type	dbr:Subsidiary
dbo:wikiPageExternalLink	https://sparktx.com/
dbo:wikiPageID	55811875 (xsd:integer)
dbo:wikiPageLength	10603 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1102109041 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Roche dbr:Hoffmann-La_Roche dbr:Pennsylvania dbr:Pfizer dbr:Pharmaceutical dbr:Voretigene_neparvovec dbr:Public_company dbc:Biotechnology_companies_of_the_United_States dbr:Gene_therapy dbr:Batten_disease dbr:Choroideremia dbr:Haemophilia_A dbc:2013_establishments_in_Pennsylvania dbc:Companies_based_in_Philadelphia dbr:Adeno-associated_virus dbc:Health_care_companies_based_in_Pennsylvania dbr:U.S._Food_and_Drug_Administration dbr:Katherine_A._High dbc:2019_mergers_and_acquisitions dbc:American_subsidiaries_of_foreign_companies dbr:Food_and_Drug_Administration dbr:Central_nervous_system dbr:Glycogen dbc:Companies_formerly_listed_on_the_Nasdaq dbr:Haemophilia dbr:Subsidiary dbc:Biopharmaceutical_companies dbc:Pharmaceutical_companies_of_the_United_States dbc:Biotechnology_companies_established_in_2013 dbc:Pharmaceutical_companies_established_in_2013 dbc:2015_initial_public_offerings dbc:Haemophilia dbr:Children's_Hospital_of_Philadelphia dbr:Biotechnology dbc:Virotherapy dbr:Philadelphia dbr:Initial_public_offering dbc:Roche dbr:Experimental_drug dbr:Factor_IX dbr:Factor_VIII dbr:Leber's_congenital_amaurosis dbr:Phases_of_clinical_research dbr:Pompe_disease dbr:Hemophilia_B dbr:Katherine_High
dbp:assets	8.14E8
dbp:equity	4.96E8
dbp:founders	Katherine A. HighJeffrey MarrazzoJean BennettJ Fraser WrightBeverly DavidsonJennifer Wellman (en)
dbp:industry	BiotechnologyPharmaceutical (en)
dbp:location	dbr:Pennsylvania dbr:Philadelphia
dbp:logo	Spark Therapeutics Label.png (en)
dbp:name	Spark Therapeutics, Inc. (en)
dbp:netIncome	-$78 million (en)
dbp:numEmployees	368 (xsd:integer)
dbp:parent	dbr:Hoffmann-La_Roche
dbp:revenue	6.4E7
dbp:type	Subsidiary of Hoffmann-La Roche (en)
dbp:website	https://sparktx.com/
dbp:wikiPageUsesTemplate	dbt:Decrease dbt:Increase dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Start_date_and_age
dcterms:subject	dbc:Biotechnology_companies_of_the_United_States dbc:2013_establishments_in_Pennsylvania dbc:Companies_based_in_Philadelphia dbc:Health_care_companies_based_in_Pennsylvania dbc:2019_mergers_and_acquisitions dbc:American_subsidiaries_of_foreign_companies dbc:Companies_formerly_listed_on_the_Nasdaq dbc:Biopharmaceutical_companies dbc:Pharmaceutical_companies_of_the_United_States dbc:Biotechnology_companies_established_in_2013 dbc:Pharmaceutical_companies_established_in_2013 dbc:2015_initial_public_offerings dbc:Haemophilia dbc:Virotherapy dbc:Roche
rdf:type	owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment	Spark Therapeutics, Inc. is a developer of gene therapy treatments, which treat debilitating genetic diseases. It is a subsidiary of Hoffmann-La Roche. (en)
rdfs:label	Spark Therapeutics (en)
owl:sameAs	wikidata:Spark Therapeutics https://global.dbpedia.org/id/2ok2K dbr:Spark Therapeutics
prov:wasDerivedFrom	wikipedia-en:Spark_Therapeutics?oldid=1102109041&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Spark_Therapeutics_Label.png
foaf:homepage	https://sparktx.com/
foaf:isPrimaryTopicOf	wikipedia-en:Spark_Therapeutics
foaf:name	Spark Therapeutics, Inc. (en)
is dbo:institution of	dbr:Katherine_A._High
is dbo:wikiPageRedirects of	dbr:Fidanacogene_elaparvovec
is dbo:wikiPageWikiLink of	dbr:Roche dbr:List_of_drugs_granted_breakthrough_therapy_designation dbr:Priority_review dbr:Unnatural_Selection_(TV_series) dbr:Voretigene_neparvovec dbr:Gene_therapy dbr:National_Organization_for_Rare_Disorders dbr:Centerview_Partners dbr:Katherine_A._High dbr:Economy_of_Philadelphia dbr:Philadelphia dbr:Robert_de_La_Berge dbr:Virotherapy dbr:Fidanacogene_elaparvovec
is dbp:workplaces of	dbr:Katherine_A._High
is foaf:primaryTopic of	wikipedia-en:Spark_Therapeutics